Skip to main content

Table 1 Study population characteristics

From: Dialysate cell-free mitochondrial DNA fragments as a marker of intraperitoneal inflammation and peritoneal solute transport rate in peritoneal dialysis

 

Total (189)

Sex (male: female)

105:84

Age (years)

47.1 ± 13.5

Primary renal disease

 Chronic glomerulonephritis (%)

133 (70.4)

 Diabetic nephropathy (%)

10 (5.3)

 Hypertensive nephrosclerosis (%)

21 (11.1)

 Obstructive nephropathy (%)

8 (4.2)

 Polycystic kidneys (%)

4 (2.1)

 Other/unknown (%)

13 (6.9)

BMI (kg/m2)

21.0 ± 3.0

Diabetes (%)

23 (12.2)

CCI

3.0 ± 1.3

Hemoglobin (g/dL)

8.2 ± 1.6

Serum albumin (g/L)

38.1 ± 5.4

hs-CRP (mg/dL)

2.4 (1.1–4.1)

Residual GFR (ml/min)

7.3 ± 2.5

urine volume (ml/24 h)

900 (500–1300)

Ultrafiltration volume (ml/24)

250 (100–500)

Total dialysate volume (L/24 h)

5.5 ± 1.4

Dialysate glucose exposure (g/24 h)

90 (60–110)

2.5% glucose solution use (%)

97 (51.3)

Peritoneal transport status

 High (%)

18 (9.5)

 High average (%)

57 (30.2)

 Low average (%)

57 (30.2)

 Low (%)

20 (10.6)

PSTR(4 h)

0.66 ± 0.12

Time of PET (months)

2.7 (1.9–4.7)

Peritoneal Kt/Vurea

1.11 ± 0.45

Total Kt/Vurea

2.15 ± 0.56

Follow-up (months)

41.9 (22.4–63.5)

  1. Abbreviations: BMI, body mass index; CCI, Charlson comorbidity index; hs-CRP, high sensitivity C-reactive protein; Residual GFR, residual glomerular filtration rate; PSTR, Peritoneal solute transport rate; PET, Peritoneal equilibration test